ketamine has been researched along with Leukoma in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have observed that the commonly used ketamine/xylazine anesthesia mix can induce a focally severe and permanent corneal opacity." | 3.81 | Ketamine/Xylazine-Induced Corneal Damage in Mice. ( Anderson, MG; Koehn, D; Meyer, KJ; Syed, NA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koehn, D | 1 |
| Meyer, KJ | 1 |
| Syed, NA | 1 |
| Anderson, MG | 1 |
| Lee, SH | 1 |
| Leem, HS | 1 |
| Jeong, SM | 1 |
| Lee, K | 1 |
2 other studies available for ketamine and Leukoma
| Article | Year |
|---|---|
Ketamine/Xylazine-Induced Corneal Damage in Mice.
Topics: Anesthesia; Animals; Cornea; Corneal Opacity; Ketamine; Mice; Xylazine | 2015 |
Bevacizumab accelerates corneal wound healing by inhibiting TGF-beta2 expression in alkali-burned mouse cornea.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Cornea; Corneal Inj | 2009 |